BioWorld® - Medical Device Daily

Biogenie Inc.
BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
350 Franquet Street
Quebec G1P 4P3, Canada
Phone: (418) 653-2074; Fax: (418) 653-2675
Toll-free phone: (877) 653-2074
Web: www.biogenie-env.com
E-mail: marketing@biogenie-env.com
KEY PERSONNEL: Benoit Cyr; President
Carl Rodzewich; GM, U.S.
Dominic Belanger; GM, Paris
Graham Holtom; GM, U.K.
Richard Corbin; Corporate Director
Bryan O’Gallagher; Project Director
EMPLOYEES: 140 employees
HISTORY: Founded in 1986
FACILITIES: 28,000 sq. ft. facility including engineering and laboratory space for chemical
analysis, microbiology and process simulation
Operates mobile units for soil biotreatment studies
STOCK-FINANCIAL HISTORY: Privately held
BUSINESS STRATEGY: Develop biological processes for the treatment of soil, water effluents and air
Seek research contracts, joint ventures and technology transfer
RESEARCH & DEVELOPMENT: Microorganisms, bioreactors, biological and physical/chemical processes for
treatment of contaminated soil, water and air
PRODUCTS ON MARKET: Soil and groundwater decontamination for organic contaminants:
hydrocarbons, solvents, pentachlorophenol, creosote, polyaromatic
hydrocarbons (PAH), nitroaromatics and inorganic contaminants such as
mercury
Waste gas biofilters and air quality services
Bio-Lab Ltd.
P.O. Box 34038
Jerusalem 91340, Israel
Phone: +972 2-584 1110; Fax: +972 2-584 1111
Web: www.bio-lab.co.il; E-mail: bio_lab@netvision.net.il
KEY PERSONNEL: Dr. Leo Samuel; Managing Director
Dr. Michel Ehrenfreund; Managing Director
Dr. Jean Hildesheim; Director, Biotech and R&D
EMPLOYEES: 75 employees
HISTORY: Founded in 1974
FACILITIES: 7,000 sq. m. facility in Jerusalem
STOCK-FINANCIAL HISTORY: Privately held
BUSINESS STRATEGY: Produce and distribute high purity solvents and chemicals for research,
routine laboratories and industries
RESEARCH & DEVELOPMENT: HPLC: Up-grading of current specifications, introduction of new products
Molecular biology: Up grading of current specifications, introduction of new
products
DNA synthesis: Up grading of current specifications, introduction of new
products, synthesis of new reagents
Peptide synthesis: Development of formulations, quality up grading of
reagents, blocked amino-acid
Copyright ©2006 AHC Media ® 70